Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Salbutamol on Cortical Excitability and Cerebral Activation
NCT02925130Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Oct 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of salbutamol in asthma (3 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Maximal voluntary activation. Started Oct 2016; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02925130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02925130.